Expert Analysis From EASL 2011

June 19, 2011

INDEPENDENT CONFERENCE COVERAGE

2011 Annual Meeting of the European Association for the Study of the Liver*

*CCO is an independent medical education company that provides state-of-the-art

medical information to healthcare professionals through conference coverage and

other educational programs.

To:

CCO member

From:

Stefan Zeuzem, MD

JW Goethe University Hospital

furt, Germany

Subject:

CME-Certified Expert Analysis From EASL 2011

Click to Access:

Clinical Impact of New Data From EASL 2011

While attending the annual EASL meeting in Berlin, I met with Graham R. ,

FRCP, PhD, and Y. Kwo, MD, to review some of the most noteworthy data

presented. Our discussion is now available on the Clinical Care Options Web site

as a CME-certified Expert Analysis. Select topics include:

REALIZE: Telaprevir Plus Peginterferon alfa-2a/Ribavirin in Patients With

Genotype 1 HCV Who Failed Previous Peginterferon/Ribavirin

Response to Boceprevir Plus Peginterferon alfa-2a/Ribavirin in Genotype 1 HCV

Patients With Advanced Fibrosis/Cirrhosis

Predictive Value of IL28B Genotype in SPRINT-2 and RESPOND-2 Phase III

Boceprevir Trials

Analyses of Treatment-Emergent Telaprevir- or Boceprevir-Resistant HCV Variants

Investigational HCV Agents Combined With Peginterferon alfa-2a/Ribavirin: BI

201355, Mericitabine, or TMC435

Investigational Combinations of DAAs, With or Without Peginterferon/Ribavirin:

BMS-790052 and BMS-650032; PSI-938 and PSI-7977; VX-222 and Telaprevir

Peginterferon Lambda/Ribavirin vs Peginterferon alfa-2a/Ribavirin in

Treatment-Naive Patients

Combining Sorafenib and TACE for Advanced Hepatocellular Carcinoma

Addition of Metformin or Losartan to Rosiglitazone vs Rosiglitazone Alone in

Patients With NASH

To review this CME-certified Expert Analysis, click here.

This Expert Analysis is located online at:

http://clinicaloptions.com/Hepatitis/Conference%20Coverage/Berlin%202011.aspx

Jointly sponsored by the Annenberg Center for Health Sciences at Eisenhower and

Clinical Care Options, LLC.

Release date: June 6, 2011

Expiration date: June 5, 2012

Supported by educational grants from Bristol-Myers Squibb; Pharmasset, Inc.; and

Vertex.

Clinical Care Options Hepatitis

GET MORE FROM CCO

Visit the CCO Hepatitis Free Bookstore

Request your free copies of popular print programs from Clinical Care Options.

Available in the United States and

Canada only.

Click here to start.

Follow Us On Twitter

Conference Coverage

Journal Options

Management Series

Treatment Updates

Interactive Cases

Like Us on Facebook

Live Meetings

RSS / Podcasts

My CME Tracker

Free Bookstore

Slide Downloads

White Drive, Suite 110, Reston, VA 20191-5433

To ensure you receive Clinical Care Options educational materials by email,

please add

info@... to your contacts or address book.

Not a member yet? Click here |

June 19, 2011